Bionano Genomics, Inc.
BNGO
$0.7872
-$0.0286-3.51%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 10.72M | 9.32M | 8.66M | 7.42M | 8.22M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 10.72M | 9.32M | 8.66M | 7.42M | 8.22M |
| Cost of Revenue | 8.28M | 6.57M | 6.35M | 5.35M | 6.41M |
| Gross Profit | 2.44M | 2.75M | 2.31M | 2.07M | 1.81M |
| SG&A Expenses | 19.68M | 24.90M | 26.94M | 25.98M | 23.44M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 39.66M | 45.25M | 47.90M | 45.26M | 43.86M |
| Operating Income | -28.94M | -35.93M | -39.24M | -37.84M | -35.65M |
| Income Before Tax | -43.93M | -112.53M | -38.88M | -37.10M | -36.87M |
| Income Tax Expenses | -36.00K | 39.00K | 33.00K | 26.00K | 1.81M |
| Earnings from Continuing Operations | -43.89M | -112.57M | -38.91M | -37.12M | -38.68M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -43.89M | -112.57M | -38.91M | -37.12M | -38.68M |
| EBIT | -28.94M | -35.93M | -39.24M | -37.84M | -35.65M |
| EBITDA | -25.35M | -32.41M | -35.84M | -34.65M | -32.88M |
| EPS Basic | -1.10 | -3.22 | -1.24 | -1.23 | -1.30 |
| Normalized Basic EPS | -0.75 | -0.63 | -0.77 | -0.77 | -0.73 |
| EPS Diluted | -1.10 | -3.22 | -1.24 | -1.23 | -1.30 |
| Normalized Diluted EPS | -0.75 | -0.63 | -0.77 | -0.77 | -0.73 |
| Average Basic Shares Outstanding | 39.86M | 35.00M | 31.50M | 30.20M | 29.70M |
| Average Diluted Shares Outstanding | 39.86M | 35.00M | 31.50M | 30.20M | 29.70M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
